PrimeVigilance

16/10/2023

📣 Webinar Alert: „Challenges in Global Literature Monitoring for Pharmacovigilance“

Are you a Biotech or Pharma professional navigating the complex world of Pharmacovigilance? Your success hinges on effective literature monitoring, and we've got the insights you need!

Join us on November 16th for a deep dive into the world of Pharmacovigilance with PrimeVigilance expert speaker, Kristijan Sašilo, Associate Director of Literature.

Key Takeaways:
🔍 Solid Search Strategy
📊 Database Selection
🔄 Dealing with Duplicates
📝 Regulatory Compliance
🌍 Global Literature Screening Trends

Register NOW: https://obi41.nl/3bkcww99

Don't miss out on this opportunity to stay ahead in the field of Pharmacovigilance. Mark your calendars and register now to secure your spot!

09/10/2023

🎥 Look back at PrimeVigilance exhibiting at the World Drug Safety Congress Europe 2023! Our team was on display at Booth #14, engaging in fruitful discussions and networking, strengthening our commitment to ensuring the safety of medicines worldwide.

If you missed meeting us in person, don't worry! You can catch up with our team at the upcoming World Drug Safety Congress Americas on 18th October.

Mark your calendars for WDSC Americas 2023!

06/10/2023

🏃‍♂️ TEAM SPIRIT IN ACTION - Our employees from Croatia, Serbia, and Bosnia & Herzegovina were proud to represent ERGOMED & PrimeVigilance at B2B Runs across the region this past month!

We believe in the power of unity and teamwork. It's not just about business for us; it's about building strong bonds, staying active, and embracing new horizons as a team. 💪

We ran together, laughed together, and cheered each other on, reminding us all that when we work together, we achieve remarkable results - both on and off the track!

A big shoutout to our team members who participated; your dedication and team spirit make this such a fantastic workplace!

05/10/2023

🌟 LIVE FROM AMSTERDAM - Join Us Today at World Drug Safety Congress Europe 2023!

Swipe through to meet the faces behind PrimeVigilance at 📍 Booth #14, where we'll showcase our dynamic team, cutting-edge technologies, and commitment to revolutionizing pharmacovigilance.
Don't miss this opportunity to gain valuable insights and discover how PrimeVigilance can elevate your medical information and communication strategies.

Let's come together to advance drug safety for the betterment of patients worldwide!

! 🌍

03/10/2023

💊 Our PrimeVigilance team is gearing up for an exciting week ahead as we prepare to exhibit at the World Drug Safety Congress Europe 2023!

If you plan to attend, pay us a visit at 📍 Booth #14. Our experts are looking forward to exchanging ideas, sharing expertise, and collaborating in advancing drug safety to benefit patients worldwide.

Mark your calendar for a compelling presentation by Noelle Humphrey, Vice President of Quality at PrimeVigilance, as she shares insights on "Ensuring Quality When Outsourcing Pharmacovigilance" tomorrow. You won't want to miss it!

See you at ! 🌍

02/10/2023

🎗️ October marks the beginning of Breast Cancer Awareness Month! Today, we would like to shed light on the importance of early detection in enhancing outcomes and ultimately saving lives.

1️⃣ Self-Awareness:
Self-examinations can be instrumental in early detection. Empower yourself with knowledge about your body, and promptly seek medical advice if you observe any anomalies.

2️⃣ Routine Screenings:
Mammograms and clinical breast examinations are indispensable tools for early detection. We urge everyone to prioritize and schedule these screenings.

3️⃣ Family History:
Being proactive is crucial if you have a family history of breast cancer. Discuss your risk factors with your healthcare provider and establish a tailored screening plan.

Let us unite in our dedication to raising awareness, supporting those affected, and promoting early detection throughout Breast Cancer Awareness Month!

08/09/2023

🚀 INSIGHTS HUB – PrimeVigilance latest trending topic explores the PAVIA Project, a blueprint for strengthening pharmacovigilance systems in resource-limited countries burdened by poverty-related diseases. The PAVIA project established collaborative triangles within each participating country in Sub-Saharan Africa (SSA), utilizing the combined experience and expertise of local regulatory authorities, national treatment programmes, and Medical Research Institutes (MRI).

PrimeVigilance, having a pool of SMEs around the globe and being involved in risk-based minimization of post-market safety surveillance activities from high-income countries (HICs) and low-income ones (LICs), can support SSA Public Health Programmes (PHPs) and MAHs in the implementation of bespoke safety solutions.

Read the full report here: https://okt.to/oHBOvl

Stay tuned for more updates on the latest developments in pharmacovigilance and the pharmaceutical industry!

06/09/2023

EVENT – PrimeVigilance Drug Safety experts Nebojša Jankov and Nikola Stojanovic were proud to be present at the "IAPC-10 Meeting: Joint World Conferences on Physico Chemical Methods in Drug Discovery and Development & ADMET and DMPK" in Belgrade, Serbia this week!

This event was a perfect precursor to the upcoming World Patient Safety Day, a day that celebrates the commitment to patient safety and encourages the global community to unite for this crucial cause. Stay tuned as we look forward to commemorating World Patient Safety Day, and let's continue to champion the values of expertise, innovation, and patient well-being. 🌍💊

06/09/2023

Uncover Drug Safety Expertise with PrimeVigilance! 💉 The PrimeVigilance team looks forward to exhibiting at the World Drug Safety Congress Europe 2023 in Amsterdam, NL, between 4-5 October 2023.

This event will bring together 1500+ key thought leaders to explore key challenges in pharmacovigilance. If attending, make sure to stop by PrimeVigilance 📍 Booth #14, where our esteemed president, Sally Amanuel, dynamic commercial team, and accomplished drug safety experts will be available to address your pivotal challenges in pharmacovigilance. We look forward to exchanging ideas, sharing expertise, and contributing to advancing drug safety for the betterment of patients worldwide. See you there!

Reserve a slot for a meeting: https://okt.to/Hj0wZv

05/09/2023

Source (European Medicines Agency) Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 💊 28-31 August 2023:

👉At its monthly meeting, EMA’s safety committee (PRAC) recommended new measures to avoid exposure of children to topiramate-containing medicines in the womb because the medicine may increase the risk of neurodevelopmental problems after exposure during pregnancy.

👉Additionally, PRAC released new safety information for healthcare professionals as well as restrictions to prevent exposure during pregnancy.

For more information, please access the meeting highlights by clicking on the following link: https://okt.to/2Aha6U

Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 28-31 August 2023